Compounded semaglutide availability has fluctuated due to regulatory changes
NexLife may work with pharmacy partners that hold recognized quality, safety, and compliance credentials, which may include LegitScript certification, PCAB accreditation where applicable, state board licensure, FDA registration for 503B outsourcing facilities, and other pharmacy-specific credentials
Methods Study design The SEMPA trial (Effect of Empagliflozin and Semaglutide on Cardio-Renal Target Organ Damage in Patients with Type 2 Diabetes A Randomized Trial) was a 32 week investigator-initiated, randomised, partly placebo-controlled, partly open-label trial, designed to assess the separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and arterial stiffness as two co-primary outcomes
Wegovy This is a drug constituted of the active ingredient semaglutide and delivered via injection once weekly to assist with weight loss
Semaglutide belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist class and works in response to elevated blood glucose levels
